Latest Revenue Generation News

Page 2 of 45
Hydralyte LLC recorded its first monthly operating profit in August, while a major cost reset cut its quarterly operating loss to US$66,900. But revenue fell 21.9%, cash narrowed to US$173,400 and the company is seeking up to A$1.4 million through a rights issue.
Victor Sage
Victor Sage
30 Oct 2026
Way2VAT is betting that its new Way2Invoice platform, Coupa distribution and Go-Global partnership can convert product momentum into recurring revenue, while a 15% cost reduction begins to address ongoing cash burn. Quarterly revenue was broadly flat at A$1.90 million, with A$3.05 million in cash and A$5.20 million of debt drawn at quarter end.
Victor Sage
Victor Sage
30 Oct 2026
Vitasora Health has signed a Florida healthcare agreement covering an initially addressable 9,000 Medicare patients while estimated October billable care minutes rose 50%. The ASX-listed company also agreed terms for an A$3 million secured facility, but the funding is not yet drawn and carries approval, interest and dilution conditions.
Ada Torres
Ada Torres
30 Oct 2026
Vection Technologies has started FY27 with stronger customer receipts, a sharply narrower operating cash loss and A$7.0 million in quarter-end cash. The next test is whether Defence, Retelit and URBANnext commitments convert into reported revenue through the year.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Change Financial delivered record quarterly PaaS revenue and pushed active cards beyond 172,000 in the September quarter, while operating cash flow turned positive. The broader revenue result softened as higher-margin one-off licence work fell away, but the company retained its FY27 net cash flow positive outlook.
Victor Sage
Victor Sage
30 Oct 2026
Blue Star Helium has recorded its first commercial helium sales from the Pinon Canyon plant in Colorado, delivering five tube trailers during the September quarter. The milestone comes with an extended offtake agreement through March 2027, but production growth still depends on permits, well development and funding.
Victor Sage
Victor Sage
30 Oct 2026
Cyclopharm has reported record third-quarter US Technegas revenue of A$1.62 million, with 76% generated by recurring consumable orders. Its installed base and hospital pipeline expanded sharply after new clinical guidelines preferred Technegas when available, while quarterly cash burn fell to A$0.9 million.
Ada Torres
Ada Torres
29 Oct 2026
SRJ Technologies has won a US$301,000 purchase order for its BoltEx flange integrity technology, marking its first significant deployment in the Middle East. The full contract value is scheduled to be paid before delivery to the end operator, giving the order unusually strong payment protection.
Victor Sage
Victor Sage
29 Oct 2026
Andromeda Metals has lifted independently verified high-purity alumina output to 99.9989% at its continuous pilot plant and sent its first commercial sample to a potential Japanese customer. The result strengthens the technical case for its HPA project, but customer qualification and commercial-scale production remain ahead.
Victor Sage
Victor Sage
29 Oct 2026
Botanix’s Sofdra prescriptions rose 5.3% in the September quarter, but flat net revenue and a sharp cash decline have forced a major reset. The company is targeting a roughly 50% reduction in operating expenses while assessing licensing, acquisitions and broader strategic transactions.
Victor Sage
Victor Sage
27 Oct 2026
ReNerve has reported its strongest quarter yet, with sales climbing to $584,000 as the medical device company expands across Asia-Pacific. The growth came alongside a secured funding drawdown, leaving the company with $1.62 million in cash but continued negative operating cash flow.
Victor Sage
Victor Sage
26 Oct 2026
AML3D has secured an approximately $2.2 million order from Northrop Grumman Marine Systems for a large-scale ARCEMY X metal additive manufacturing system. The contract gives AML3D its first engagement with the US defence prime and expands its contracted US base to 17 ARCEMY systems.
Victor Sage
Victor Sage
26 Oct 2026

Browse the archive

Full archive